Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares, rose in value, with the stock price down by -30.43% to the previous day’s close as strong demand from buyers drove the stock to $1.60.
Actively observing the price movement in the last trading, the stock closed the session at $2.30. Referring to stock’s 52-week performance, its high was $13.20, and the low was $1.52. On the whole, CYCC has fluctuated by -16.67% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CYCC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CYCC currently trading nearly -18.70% and -30.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.53, while the 7-day volatility ratio is showing 19.94% which for the 30-day chart, stands at 11.81%. Furthermore, Cyclacel Pharmaceuticals Inc (CYCC)’s beta value is 0.53, and its average true range (ATR) is 0.27.
A comparison of Cyclacel Pharmaceuticals Inc (CYCC) with its peers suggests the former has fared considerably weaker in the market. CYCC showed an intraday change of -30.43% in last session, and over the past year, it shrunk by -82.52%%.
Data on historical trading for Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) indicates that the trading volumes over the past 3 months, they’ve averaged 53.49K. According to company’s latest data on outstanding shares, there are 1.32 million shares outstanding.
Nearly 8.89% of Cyclacel Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 7.12% of the company’s shares. The stock has fallen by -40.07% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CYCC stock heading into the next quarter.
